Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Glioma × Aminolevulinic Acid × Clear all

Phase

Phase 1 5 Phase 2 4 Phase 1/2 3 Phase NA 2 Phase 3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Keratosis, Actinic 5 Skin Diseases 2 Precancerous Conditions 2 Urinary Bladder Neoplasms 1 Ovarian Neoplasms 1 Meningioma 1 Glioma 1 Carcinoma, Basal Cell 1 Breast Neoplasms 1 Brain Neoplasms 1

Interventions

Temozolomide 7 Radiotherapy 7 Lomustine 6 Procarbazine 4 Carmustine 4 Bevacizumab 4 Vincristine 3 Administration, Oral 2 vorasidenib 1 fluorodopa F 18 1 contrast agent BR1 1 carmustine, poliferprosan 20 drug combination 1 Valproic Acid 1 Tranexamic Acid 1 Trabedersen 1 TIC10 compound 1 Surgical Procedures, Operative 1 Radiotherapy, Intensity-Modulated 1 Radiotherapy, Conformal 1 Radiation 1 Microbubbles 1 Methylphenidate 1 Methods 1 Isotretinoin 1 Infusions, Intravenous 1 IL13-PE38 1 Fentanyl 1 Eflornithine 1 Drug Delivery Systems 1 Donepezil 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01502280 2023-11-24

BALANCE

St. Joseph's Hospital and Medical Center, Phoenix

Phase 3 Completed

Glioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡